Compare CRESY & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CRESY | CBLL |
|---|---|---|
| Founded | 1936 | 2014 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 804.3M | 935.3M |
| IPO Year | 1997 | 2024 |
| Metric | CRESY | CBLL |
|---|---|---|
| Price | $11.46 | $27.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $15.86 | ★ $28.57 |
| AVG Volume (30 Days) | 201.5K | ★ 380.0K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | ★ 5.59% | N/A |
| EPS Growth | N/A | ★ 56.93 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $89,063,000.00 |
| Revenue This Year | $14.96 | $29.66 |
| Revenue Next Year | $19.02 | $27.36 |
| P/E Ratio | $6.92 | ★ N/A |
| Revenue Growth | N/A | ★ 36.09 |
| 52 Week Low | $10.26 | $10.85 |
| 52 Week High | $14.21 | $28.11 |
| Indicator | CRESY | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 60.73 |
| Support Level | $11.18 | $22.64 |
| Resistance Level | $11.74 | N/A |
| Average True Range (ATR) | 0.39 | 1.52 |
| MACD | -0.05 | 0.22 |
| Stochastic Oscillator | 39.58 | 86.16 |
Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.